| Recent advances in nanoparticle-based cancer drug and gene delivery N Amreddy, A Babu, R Muralidharan, J Panneerselvam, A Srivastava, ... Advances in cancer research 137, 115-170, 2018 | 217 | 2018 |
| Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells A Srivastava, N Amreddy, A Babu, J Panneerselvam, M Mehta, ... Scientific reports 6 (1), 38541, 2016 | 162 | 2016 |
| Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment N Amreddy, A Babu, J Panneerselvam, A Srivastava, R Muralidharan, ... Nanomedicine: Nanotechnology, Biology and Medicine 14 (2), 373-384, 2018 | 118 | 2018 |
| IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis J Panneerselvam, J Jin, M Shanker, J Lauderdale, J Bates, Q Wang, ... PloS one 10 (3), e0122439, 2015 | 71 | 2015 |
| Chemopreventive effect of bacoside A on N-nitrosodiethylamine-induced hepatocarcinogenesis in rats P Janani, K Sivakumari, A Geetha, B Ravisankar, C Parthasarathy Journal of cancer research and clinical oncology 136, 759-770, 2010 | 69 | 2010 |
| Hepatoprotective activity of bacoside A against N-nitrosodiethylamine-induced liver toxicity in adult rats P Janani, K Sivakumari, C Parthasarathy Cell biology and toxicology 25, 425-434, 2009 | 59 | 2009 |
| Regulatory roles of Dclk1 in epithelial mesenchymal transition and cancer stem cells P Chandrakesan, J Panneerselvam, D Qu, N Weygant, R May, MS Bronze, ... Journal of carcinogenesis & mutagenesis 7 (2), 2016 | 50 | 2016 |
| HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer R Muralidharan, J Panneerselvam, A Chen, YD Zhao, A Munshi, ... Cancer gene therapy 22 (12), 581-590, 2015 | 47 | 2015 |
| YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways D Andrade, M Mehta, J Griffith, J Panneerselvam, A Srivastava, TD Kim, ... Oncotarget 8 (58), 98495, 2017 | 45 | 2017 |
| Molecular targets and signaling pathways regulated by interleukin (IL)-24 in mediating its antitumor activities J Panneerselvam, A Munshi, R Ramesh Journal of Molecular Signaling 8 (1), 1-14, 2013 | 43 | 2013 |
| Bacoside A downregulates matrix metalloproteinases 2 and 9 in DEN‐induced hepatocellular carcinoma P Janani, K Sivakumari, A Geetha, S Yuvaraj, C Parthasarathy Cell Biochemistry and Function: Cellular biochemistry and its modulation by …, 2010 | 36 | 2010 |
| Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention NS Yarla, H Gali, G Pathuri, S Smriti, M Farooqui, J Panneerselvam, ... Seminars in cancer biology 56, 168-174, 2019 | 31 | 2019 |
| DCLK1 regulates tumor stemness and cisplatin resistance in non-small cell lung cancer via ABCD-member-4 J Panneerselvam, P Mohandoss, R Patel, H Gillan, M Li, K Kumar, ... Molecular Therapy-Oncolytics 18, 24-36, 2020 | 30 | 2020 |
| IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells RR Panneerselvam J, Srivastava A, Muralidharan R, Wang Q, Zheng W, Zhao L ... Oncotarget 7, 70247-70263, 2016 | 30 | 2016 |
| DCLK1-isoform2 alternative splice variant promotes pancreatic tumor immunosuppressive M2-macrophage polarization P Chandrakesan, J Panneerselvam, R May, N Weygant, D Qu, WR Berry, ... Molecular cancer therapeutics 19 (7), 1539-1549, 2020 | 27 | 2020 |
| Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage M Mehta, J Griffith, J Panneerselvam, A Babu, J Mani, T Herman, ... International journal of radiation biology 97 (8), 1109-1120, 2021 | 23 | 2021 |
| Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity J Panneerselvam, M Shanker, J Jin, CD Branch, R Muralidharan, ... Oncotarget 6 (18), 16271, 2015 | 18 | 2015 |
| Inflammatory mediators and gut microbial toxins drive colon tumorigenesis by IL-23 dependent mechanism J Panneerselvam, V Madka, R Rai, KT Morris, CW Houchen, ... Cancers 13 (20), 5159, 2021 | 12 | 2021 |
| IL-24 inhibits lung cancer growth by suppressing GLI1 and inducing DNA damage J Panneerselvam, A Srivastava, M Mehta, A Chen, YD Zhao, A Munshi, ... Cancers 11 (12), 1879, 2019 | 12 | 2019 |
| Discovery and development of a novel mPGES-1/5-LOX dual inhibitor LFA-9 for prevention and treatment of chronic inflammatory diseases NS Yarla, G Pathuri, H Gali, S Terzyan, J Panneerselvam, ... Journal of Inflammation Research, 1261-1278, 2020 | 10 | 2020 |
Parthasarathy ChandrakesanDirector Research & Development, Wild Earth, Former Associate Professor, Member of Stepenson CancerVerified email at wildearth.com
